Metraipolis › archive › dc_95bfbcd8530e

Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey — Europe PMC PMID:41848413

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41848413
DOI: 10.1111/dar.70132
License (as archived): solo-consultazione
Archived: 2026-11-05T11:08:57.197Z
SHA-256 of the archived text: 6f1c72187feda260cfc1c1de60d905ebf24897e152119f777bd02ad6581256f6
Stable URL of this page: https://metraipolis.com/documento/dc_95bfbcd8530e

How to cite

Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey — Europe PMC PMID:41848413 — Europe PMC (en), https://europepmc.org/article/MED/41848413 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_95bfbcd8530e (Metraipolis archive dc_95bfbcd8530e, sha256 6f1c72187feda260cfc1c1de60d905ebf24897e152119f777bd02ad6581256f6)

BibTeX

@misc{dc95bfbcd8530e,
  title = {Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey — Europe PMC PMID:41848413},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41848413},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_95bfbcd8530e; sha256 6f1c72187feda260cfc1c1de60d905ebf24897e152119f777bd02ad6581256f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41848413. Agents can read the archived copy with the MCP tool read_document.